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Herpes Simplex Virus 34.5 Interferes with Autophagosome
Maturation and Antigen Presentation in Dendritic Cells
Philipe A. M. Gobeil and David A. Leib
Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA
ABSTRACT The cellular autophagy response induced by herpes simplex virus 1 (HSV-1) is countered by the viral 34.5 protein.
34.5 modulates autophagy by binding to the host autophagy protein Beclin-1 and through this binding inhibits the formation
of autophagosomes in fibroblasts and neurons. In contrast, in this study dendritic cells (DCs) infected with HSV-1 showed an
accumulation of autophagosomes and of the long-lived protein p62. No such accumulations were observed in DCs infected with
a 34.5-null virus or a virus lacking the Beclin-binding domain (BBD) of 34.5. To explore this further, we established stably
transduced DC lines to show that 34.5 expression alone induced autophagosome accumulation yet prevented p62 degradation.
In contrast, DCs expressing a BBD-deleted mutant of 34.5 were unable to modulate autophagy. DCs expressing 34.5 were less
capable of stimulating T-cell activation and proliferation in response to intracellular antigens, demonstrating an immunological
consequence of inhibiting autophagy. Taken together, these data show that in DCs, 34.5 antagonizes the maturation of au-
tophagosomes and T cell activation in a BBD-dependent manner, illustrating a unique interface between HSV and autophagy in
antigen-presenting cells.
IMPORTANCE Herpes simplex virus 1 (HSV-1) is a highly prevalent pathogen causing widespread morbidity and some mortality.
HSV infections are lifelong, and there are no vaccines or antivirals to cure HSV infections. The ability of HSV to modulate host
immunity is critical for its virulence. HSV inhibits host autophagy, a pathway with importance in many areas of health and dis-
ease. Autophagy is triggered by many microbes, some of which harness autophagy for replication; others evade autophagy or
prevent it from occurring. Autophagy is critical for host defense, either by directly degrading the invading pathogen (“xe-
nophagy”) or by facilitating antigen presentation to T cells. In this study, we show that HSV manipulates autophagy through an
unsuspected mechanism with a functional consequence of reducing T cell stimulation. These data further our understanding of
how HSV evades host immunity to persist for the lifetime of its host, facilitating its spread in the human population.
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Herpes simplex virus 1 (HSV-1) is a common and significantpathogen with two distinct phases of infection (1). Acute in-
fection occurs at peripheral mucocutaneous sites with widespread
expression of viral genes. Infection of innervating neurons is fol-
lowed by retrograde transport of virus to cell bodies within sen-
sory ganglia and establishment of a latent infection therein. Dur-
ing latency, viral gene expression is limited until the viral genome
reactivates to form progeny virions. Following anterograde trans-
port to the periphery, the reactivated virus may form new lesions
and be shed to infect other susceptible individuals. The ability of
HSV to repeatedly reactivate from infected individuals under-
scores both the power and importance of its immune-modulating
activities which allow HSV to replicate in, and be shed from, a
primed and immunocompetent host. One such immunomodula-
tory factor, 34.5, the focus of this study, is now emerging as a
multifunctional viral protein that is effective at manipulating both
the innate and adaptive immune responses.
Host cell translational shutdown is a key antiviral defense path-
way mediated by double-stranded RNA-dependent protein kinase
(PKR), which phosphorylates the alpha subunit of the translation
initiation factor eIF2 (2, 3). 34.5, expressed by HSV at approxi-
mately 3 h postinfection, serves to reverse this translational shut-
down by bridging protein phosphatase 1 (PP1) and eIF2, thereby
dephosphorylating eIF2 (4–8). Another target for 34.5 is Tank-
binding kinase 1 (TBK1), which is responsible for signaling to
interferon regulatory factors 3 and 7 (IRF3/7) (9, 10). 34.5
thereby inhibits IRF3/7 activation, repressing the induction of
many antiviral genes within infected cells. In addition to these
roles in modulating the innate immune response, 34.5 also reg-
ulates autophagy (11). Autophagy is a catabolic homeostatic pro-
cess involving the breakdown of cellular components in cytosolic
vacuoles (12–14). It is induced by starvation, heat shock, hypoxia,
hormones, immune signaling, and other triggers (15–19). Among
its myriad roles, autophagy is involved in survival and apoptosis,
organelle maintenance, removal of protein aggregates, and via a
process called xenophagy, direct clearance of intracellular patho-
gens (20, 21). Mechanistically, autophagy progresses through the
formation of an isolation membrane in the cytosol, which sur-
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rounds and segregates cytosolic material (22, 23). This matures to
a double-membrane structure, the autophagosome, which in turn
fuses with the lysosome leading to the enzymatic breakdown of its
contents (24, 25). Although autophagy is constitutive, the rate of
autophagosome formation and autophagic flux is tightly con-
trolled, with Beclin-1 as a major regulator (26, 27). Autophagy
also plays a key role in antigen processing for major histocompat-
ibility complex (MHC) presentation, especially to CD4 T cells
(28), and this activity is critical in vivo for protection against
HSV-2 and other pathogens (29).
Modulation of autophagy is important for the virulence of
many viruses, including HIV, hepatitis B and C, and Coxsackie B
(30–36), underscoring the importance of understanding the inter-
play between viruses and autophagy. HSV-1 mutants lacking
34.5 demonstrate a PKR- and eIF2 phosphorylation-
dependent reduction of long-lived proteins and reduced volume
of autophagic vacuoles in infected fibroblasts and neurons (11,
37). Control of autophagy by 34.5 is mediated not only by its
manipulation of eIF2 phosphorylation but also by its capacity to
bind Beclin-1 through a 20-amino-acid Beclin-binding domain
(BBD) in both mouse and human cells (38). Mutants lacking BBD
(BBD) induce increased numbers of autophagosomes in epithe-
lial cells and are neuro-attenuated in vivo (38). This attenuation of
the BBD mutant is dependent upon a functional adaptive im-
mune response, and BBD mutant-infected mice display higher
CD4 T cell responsiveness than mice infected with wild-type
virus (39). These observations suggested a possible role for 34.5
in modulation of the immune response via preclusion of au-
tophagy in antigen-presenting cells (APCs). Emerging data, how-
ever, has suggested that the effect of 34.5 on autophagy in pro-
fessional APCs may differ from that observed in fibroblasts or
neurons. In infected macrophages, 34.5 leads to the formation of
morphologically distinct autophagosomes that are associated with
the nuclear envelope, and infected cells retain the ability to prime
CD8 T cells (40). Also, in contrast to neurons and fibroblasts,
34.5 does not inhibit the induction of autophagy in dendritic
cells (DCs) (41). Finally, the maturation of infected DCs is inhib-
ited by 34.5 expression, further illustrating that 34.5 manipu-
lates immune surveillance through multiple mechanisms (42–44).
In this study, we wished to address the role of the BBD of 34.5
in alteration of the autophagy pathway in DCs. We also sought to
study the functional consequences of 34.5 expression in these
cells and to test whether 34.5 alone was sufficient for alteration of
autophagy and T cell responses to presented antigen. To address
this, we infected DCs with wild-type or mutant viruses and exam-
ined their capacity to form autophagosomes and process long-
lived proteins. We also constructed DC lines stably expressing
34.5 or its BBD mutant to examine their roles in modulation of
autophagy in the absence of expression of other HSV genes. Our
results showed that 34.5 does not prevent the induction of au-
tophagy in DCs but rather prevents the maturation of autophago-
somes. Significantly, we also illustrated a 34.5- and BBD-
dependent interference with the ability of DCs to stimulate
antigen-specific T cells. These data suggest an important role for
the BBD of 34.5 in the modulation of autophagy in DCs and
genesis of the adaptive immune response.
RESULTS
HSV-1 infection induces autophagosome accumulation in in-
fected DC2.4 cells. The conversion of LC3-I to its
phosphatidylethanolamine-conjugated form, LC3-II, is requisite
for the formation of the autophagosome and is a widely used mea-
surement of autophagy (45). When DC2.4 cells were infected with
the wild type (WT), the LC3-I isoform (top band) was reduced
and LC3-II concentrations were ~6-fold higher than in uninfected
cells and significantly higher than observed in cells infected with
34.5 and BBD mutants (Fig. 1A and B). We hypothesized that
this unexpected increased conversion of LC3 was indicative of
FIG 1 Infection of DCs with HSV leads to autophagosome accumulation. (A)
Representative Western blot (of two experiments) of lysates from DC2.4 cells
that were mock infected or infected at an MOI of 8.0 with WT, 34.5, or
BBD virus for 8 h. Blots were probed with anti-LC3 or anti--tubulin. (B)
Quantification of representative Western blot showing relative band density
for LC3-II (the 16-kDa band) normalized to -tubulin. (C) Immunofluores-
cence micrographs of cells infected at an MOI of 2.0 with WT, 34.5, or
BBD virus for 8 h and probed for autophagosomes with anti-LC3 and for
viral infection with anti-ICP8. Bystander cells without ICP8 stain serve as
internal, uninfected controls. (D) Quantification of cells displaying 4 or more
bright LC3 puncta for various treatments following analysis of at least three
experiments involving 100 cells in four or more fields for each treatment.
Positive cells are graphed as a function of total cells using DAPI for mock-
infected cultures or as a function of ICP8-positive stain for infected cultures.
Error bars indicate standard deviations between visualized fields. **, P 
0.005; ***, P  0.001 (t test).
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increased autophagy and sought to assess this further by immu-
nofluorescence microscopy. DC2.4 cells were infected with the
WT, 34.5, or BBD strain and analyzed 8 h postinfection. As a
positive control, cells were treated with bafilomycin, which causes
an accumulation of autophagosomes by preventing lysosome
acidification (46, 47). We observed a significant increase of LC3
puncta in WT-infected cells that was similar to levels seen follow-
ing bafilomycin treatment (Fig. 1C and D). In contrast, infection
with the 34.5 or BBD mutant did not result in an increase in
LC3 puncta. In these experiments, cells scored as positive for au-
tophagy contained from 20 to 60 puncta, whereas negative cells
contained 0 to 3 puncta. Uninfected bystander cells, unstained for
ICP8, did not accumulate LC3-specific puncta, indicating that the
effect is dependent upon direct infection. Based on these results,
we conclude that infection with wild-type virus, but not the
34.5 or BBD mutant, results in an increased number of LC3-
II-positive autophagosomes in DCs.
Long-lived proteins accumulate in HSV-infected dendritic
cells. While an increase in LC3 lipidation often results from in-
creased initiation of autophagy, LC3-II can also accumulate due to
interference with the maturation phase of autophagy. To differ-
entiate between these possibilities, we examined the stability of the
long-lived protein p62. p62 is primarily involved in clearing ubi-
quitinated proteins from the cell, and its degradation by au-
tophagy renders it a suitable marker for autophagic flux (48, 49).
Western blots for p62 were performed on lysates from DC2.4 cells
infected for 8 h with WT, 34.5-null, or BBD strains (Fig. 2A
and B). DC2.4 is a cell line derived from mouse bone marrow, and
in the inactive form of the cells, like the epidermal myeloid-
derived DCs infected by HSV in vivo, they are poorly inflamma-
tory and express little MHC class II (MHC-II), CD40, and CD80
(44, 50, 51). They are phagocytosis-competent and mature when
activated, upregulating MHC-II, CD40, and CD80 and secreting a
wide variety of proinflammatory cytokines and chemokines. Cells
infected with the WT had greater concentrations of p62 than un-
infected cells or cells infected with the 34.5 or BBD mutant,
indicating that HSV interferes with catabolic breakdown of p62 in
a BBD-dependent manner. These data are consistent with the hy-
pothesis that the increased number of autophagosomes in HSV-
infected dendritic cells is due to a BBD-dependent interference
with the maturation phase of autophagy, analogous to the activi-
ties of influenza A M2 and HIV-1 Nef (30, 31). To test this hypoth-
esis further, we performed immunofluorescence microscopy for
p62, with the prediction that we would see a greater number of
p62-containing puncta in WT-infected cells than in cells infected
with the 34.5 and BBD mutants (Fig. 2C and D). Untreated
cells showed p62 in a diffuse cytoplasmic pattern, in contrast to
cells treated with bafilomycin, where distinct multiple cytoplas-
mic puncta were observed in the majority of cells. Consistent with
our prediction, infection of DC2.4 with WT caused a significant
accumulation of cytoplasmic puncta compared to that of mock-
infected cells. In contrast 34.5 or BBD mutant-infected cells
did not significantly differ from mock-infected cells. Taken to-
gether, these data suggest that 34.5, through its BBD, prevents
the maturation of autophagosomes, leading to the intracellular
accumulation of p62.
Stably transduced DC2.4 lines express functional 34.5.
Having shown that the BBD of 34.5 was necessary for impacting
autophagy maturation in DCs, we next sought to determine
whether 34.5 is sufficient for this function and whether the BBD
FIG 2 p62 accumulates in DC2.4 cells infected with HSV-1. (A) Representa-
tive Western blots (from two experiments) from lysates of DC2.4 cells that
were mock infected or infected at an MOI of 8.0 with WT, 34.5, or BBD
virus for 8 h and probed with anti-p62 or anti--tubulin antibodies. (B) Graph
from representative Western blot showing relative band density for p62 nor-
malized to -tubulin. (C) Immunofluorescence micrographs of cells infected
at an MOI of 2.0 with WT, 34.5, or BBD virus for 16 h and probed for p62
and HSV ICP0 expression. (D) Quantification of cells from fluorescence mi-
crographs. Cells displaying 4 or more p62 puncta were counted as positive and
graphed as a function of total cells using DAPI for mock-infected cells or as a
function of ICP0-positive stain for infected cells. Analysis included at least 60
cells in three or more fields for each treatment in two experiments. Error bars
indicate standard deviations between visualized fields. ***, P  0.001 (t test).
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is necessary. To examine this, we used a lentivirus expression vec-
tor to create 34.5- and 34.5BBD mutant-expressing DC2.4
cell lines. Probing cell lysates from the stably transduced DC2.4
lines by Western blotting showed 34.5- and 34.5BBD mutant-
reactive bands with the expected migration patterns (data not
shown). To determine if the expressed proteins were functional in
an autophagy-independent manner, we used Western blotting to
test the levels of phosphorylated eIF2 induced by HSV-1 or
poly(I:C) treatment (Fig. 3A). 34.5 infection was used to avoid
the interfering effects of 34.5 being expressed by both the in-
fected cells and the incoming virus. Both 34.5 infection and
poly(I:C) treatment strongly induced a band detectable by an
eIF2 serine-51 phosphorylation-specific antibody in lysates from
control cells but not in cells expressing full-length 34.5 or the
34.5BBD mutant. These results demonstrated that the stably
transduced DCs were expressing 34.5 and 34.5BBD proteins
that were equally capable of mediating the dephosphorylation of
eIF2.
DC2.4 cells expressing 34.5 exhibit altered autophagy pat-
terns. We next sought to determine if the stably transduced DC2.4
lines expressing 34.5 or the 34.5BBD mutant exhibit altered
patterns of autophagy (Fig. 3B and C). We stained stably trans-
duced DC2.4 with an LC3-specific antibody and quantified cells
per field with 4 or more puncta by immunofluorescence micros-
copy. Relative to control cells, we observed a significant increase in
the number of cells with 4 LC3-positive puncta in the line ex-
pressing 34.5 but not in the control or 34.5BBD mutant lines.
All cell lines treated with bafilomycin displayed an expected in-
crease in the number of LC3-specific puncta, showing that the
pathways for induction of LC3-II were intact in all 3 cell lines.
Based on these results, we conclude that 34.5 is sufficient to cause
an increase in accumulation of LC3 puncta and that the changes in
autophagy observed during infection of DCs with HSV are due
largely to the activities of 34.5 and the BBD.
34.5 reduces cell survival following starvation and inter-
feres with autophagic flux. Autophagy is induced in cells in re-
sponse to starvation, thereby making biosynthetic precursors
available to starving cells to preclude nutritional crisis and apo-
ptosis. Cells with functional autophagy can therefore survive brief
starvation stress, while cells deficient in autophagy are less resis-
tant (52–54). We utilized this classic observation to ask whether
cells expressing wild-type 34.5 are less able to survive starvation
relative to cells expressing the 34.5BBD strain, thereby demon-
strating a block to functional autophagy and survival. To assess
this, cells were stained for the apoptosis marker annexin V during
normal culture conditions and following starvation (Fig. 4A). All
cell lines stained equivalently for annexin V under normal culture
conditions, but following a 2-h starvation, DC2.4 lines expressing
34.5, but not control cells or cells expressing the 34.5BBD
strain, had significantly increased annexin V staining. Cell viabil-
ity, as measured by propidium iodide incorporation, was also re-
duced in starved cells expressing 34.5 (data not shown). These
results indicate that despite 34.5-induced LC3-II positive
puncta, autophagy-derived catabolites are not available for de
novo biosynthesis under nutritional stress conditions, consistent
with the idea that 34.5 inhibits the maturation phase of au-
tophagy. To examine this further, we measured autophagic flux by
examining p62 concentrations in each of the 3 cell lines in the
presence and absence of bafilomycin (Fig. 4B and C). Untreated
34.5-expresssing cells exhibit higher concentrations of p62 than
FIG 3 Stably transduced DC2.4 cells express functional 34.5 and accumu-
late autophagosomes. (A) Western blot (representative of two experiments) of
cell lysates from 34.5 or BBD mutant-expressing DC2.4 cells or control
DC2.4 cells transfected with poly(I:C) at 20 g/ml or infected with 34.5
HSV-1 at an MOI of 8.0 for 12 h. Western blots were probed with an antibody
for phospho-eIF2. (B) Fluorescence micrographs of 34.5- or BBD
mutant-expressing or control cells probed with an anti-LC3 antibody. Cells
were untreated or treated with 100 M bafilomycin for 6 h. (C) Quantification
of cells from panel B displaying 4 or more LC3 puncta. At least 100 cells in 4 or
more fields were counted for each cell type and each treatment in 2 experi-
ments. Positive cells are graphed as a function of total cells using DAPI stain,
and the error bars indicate standard deviations between visualized fields. **, P
 0.005; ***, P  0.001 (t test).
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control cells or cells expressing the 34.5BBD strain, relative to
expression of -tubulin. Bafilomycin treatment leads to an accu-
mulation of p62 in all cells, showing that the pathways that pro-
mote p62 accumulation are intact in all cells. We infer from these
data that autophagic flux is reduced by 34.5 and that this activity
is dependent upon binding of Beclin-1.
Autophagy modulation by 34.5 in DCs interferes with T cell
stimulation. Autophagy is involved in the presentation of intra-
cellular antigens on MHC-II via its delivery of cytoplasmic com-
ponents to the lysosome and multivesicular MHC-II-loading
compartment (28). We hypothesized that 34.5, by virtue of in-
terfering with autophagic delivery of intracellular antigens to the
lysosome, would prevent the presentation of intracellular antigens
when expressed in DCs. To this end, we engineered a 34.5-
deficient virus that expressed a truncated form of ovalbumin
(OVA) lacking its amino-terminal signal sequence (virus termed
34.5tOVA). Truncated OVA is not secreted and accumulates in
the cytoplasm (55, 56). This makes it an attractive tool for immu-
nological analysis of intracellular antigen processing by au-
tophagy. We used 34.5tOVA in conjunction with OT-II T cell
receptor transgenic mice. OT-II mice have CD4 T cells specific to
the MHC-II immunodominant chicken ovalbumin peptide (res-
idues 323 to 339) (57, 58). We infected control DC2.4 lines or the
stably transduced lines expressing 34.5 or the 34.5BBD mu-
tant with the 34.5tOVA strain and examined their ability to
present intracellular antigen by coculturing them with splenocytes
from OT-II mice. We measured the percentage of responding
CD4 T cells with a high degree of CD44 surface expression to
quantify antigen exposure (Fig. 5). High-CD44 populations were
robustly induced in OT-II CD4 cells responding to the infected
control DC line and to the cells expressing the 34.5BBD strain.
In marked contrast, the 34.5-expressing cell line infected with
the 34.5tOVA strain did not stimulate OT-II cells. These dif-
ferences were due to the presence or absence of the BBD and
independent of the remainder of the 34.5 protein. The pheno-
FIG 4 Stably transduced DC2.4 cells expressing 34.5 are sensitive to starva-
tion and accumulate long-lived proteins. (A) Annexin V staining of DC2.4
cells stably expressing 34.5 or the BBD mutant or control cells. Cells were
untreated or starved and analyzed by flow cytometry, and mean fluorescence
intensity was recorded. Graph shows the mean from two experiments, each
consisting of at least 2 biological duplicates, and error bars indicate standard
deviations. ***, P  0.001 (t test). (B) Representative Western blot (of three
experiments) of p62 or -tubulin on cell lysates of control cells or cells express-
ing 34.5 or the BBD mutant. Cells were untreated or incubated with 100 M
bafilomycin for 6 h. (C) Quantification of a representative Western blot show-
ing band density of p62 normalized to -tubulin band density.
FIG 5 -34.5 expression in dendritic cells antagonizes activation of CD4 T
cells via Beclin-1 binding. (A) Representative flow cytometry histograms from
DC2.4 cell lines infected with the 1734.5tOva strain. Histograms represent
one of two experiments analyzing 2 biological replicates. The 34.5 or BBD
strains expressing DC2.4 cells or control cells were mock infected or infected
with the 34.5 or 34.5tOva strain. Cells were cocultured with whole spleno-
cytes from OT-II mice, stained cells were gated for CD4 T cells, and CD44
staining was measured. (B) Graph showing fold changes in percentages of
CD4 T cell populations staining high for CD44 relative to mock-infected
controls. Results are means from two experiments, each consisting of biolog-
ical duplicates. Error bars indicate standard deviations. *, P  0.05; **, P 
0.005 (t test).
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type can therefore be primarily attributed to 34.5’s effects upon
the autophagic pathway. This T cell stimulation was antigen spe-
cific since CD44 surface expression was not upregulated in re-
sponse to mock infection or infection with 34.5 HSV-1 that
lacked ovalbumin (Fig. 5B). In addition, no stimulation was ob-
served when infected DCs were cocultured with splenocytes from
nontransgenic C57BL/6 mice (data not shown). With all cocul-
tures, treatment with phorbol myristate acetate (PMA) and iono-
mycin increased CD44 surface expression in CD4 OT-II spleno-
cytes, demonstrating that the T cells were responsive regardless of
the DC lines in the coculture. We therefore conclude that 34.5
manipulates autophagosome maturation in DCs, via Beclin-1 in-
teraction, resulting in functional interference with immune sur-
veillance of intracellular antigens.
DISCUSSION
Data from a number of laboratories have suggested that 34.5
modulates autophagy during infection of fibroblasts and neurons
via two activities, binding to Beclin-1 and dephosphorylation of
eIF2 (11, 37, 38). These data were consistent with the idea that
autophagy is dependent on Beclin-1 and on the activities of PKR,
whose principle target is eIF2. Two recent studies, however, have
suggested that this model may be too simplistic, since the effect of
34.5 on autophagy appears to be cell type specific. First, and
consistent with the data in this study, induction of autophago-
somes in murine myeloid cells is not antagonized by 34.5 (41).
Second, a recent study showed that HSV-1 induces incomplete/
abortive autophagy in infected neuroblastoma cells (59). These
latter results differ from those which examined infected primary
neurons in culture (37, 38). This discordance may result from
differences in autophagy pathways in immortalized SK-N-SH cells
relative to postmitotic neurons or may simply reflect differences
between human and mouse cells. The key question, however, is
why do HSV-induced autophagy patterns differ so markedly in
different cell types? Cell permissivity has been invoked as a possi-
ble explanation for the differences between DCs and fibroblasts
(41), although this cannot be the entire explanation, since primary
DCs and neurons are both poorly permissive for productive
HSV-1 infection yet markedly differ in their autophagy responses.
Another key question is do different autophagy patterns confer
any advantage for HSV as a pathogen? It is possible that following
infection of certain cells (e.g., fibroblasts), HSV has evolved to
evade xenophagy, whereas in others (e.g., APCs), HSV has evolved
to minimize antigen presentation, to sequester pathogen-
associated molecular patterns (PAMPs) in autophagosomes, or
possibly to regulate the inflammasome (60). It is also likely that
other effects of 34.5 on DCs, such as the prevention of DC mat-
uration (42–44), impact the manner in which autophagy is inhib-
ited by 34.5 in these unique cells. Cell-specific differential use of
autophagy-related proteins, due to their shared use in phagocyto-
sis, antigen presentation, or immune modulation (61–63), may
cause invading pathogens to evolve alternative strategies to sub-
vert autophagy in different cell types. While evidence from our
laboratory suggests that 34.5 does not modulate phagocytosis in
DCs (P. A. M. Gobeil and D. A. Leib, unpublished data), this is
clearly an important area that warrants further investigation.
The initial observation of a role for 34.5 in regulating MHC-
II-restricted antigen presentation was described 10 years ago (64).
Work from our lab and others has served to show a role for 34.5
in controlling immunity through modulation of autophagy and
APC maturation which underscores the multifunctional nature of
34.5’s role in controlling immunity (42, 43, 65). The maturation
of DCs is dependent upon NF-B activation (66), which can be
suppressed through 34.5’s regulation of IKK activity (43). In-
triguingly, the posttranslational modification of IKK is also im-
portant for the control of autophagy, so it is possible that this is yet
another way in which 34.5 modulates the formation or matura-
tion of autophagosomes (67). Abortive autophagy, as observed in
this study, occurs following infection with other viruses (e.g., hep-
atitis B and C, coxsackievirus B, and influenza) in a wide variety of
cell types (31–36, 68). A close functional analog to 34.5 is HIV
Nef, which can bind Beclin-1 and blocks virus-induced autopha-
gosome maturation, causing accumulation of long-lived proteins,
lipidated LC3, and autophagosomes in infected macrophages
(30). The lack of sequence similarity between 34.5 and HIV Nef,
as well as between other viral modulators of autophagy, suggests
that these genes and their functions have evolved independently.
This mode of evolution highlights the common importance of this
pathway in controlling virulence and development of innate and
adaptive immunity.
During the revision of this report, TBK-1 was shown to be
necessary for the maturation of autophagosomes (69). TBK-1 in-
hibition leads to the accumulation of both LC3-II and p62 in a
manner comparable to bafilomycin treatment and to the effects of
34.5 described herein. This is especially of interest given that
34.5 possesses a TBK-1 binding domain which partially overlaps
the BBD (10). It could be argued, therefore, that mutagenesis of
the BBD may have caused a defect in the ability of 34.5 to mod-
ulate TBK-1 in addition to ablation of Beclin binding. While this is
a possibility, the virulence of a virus lacking BBD remained atten-
uated in mice lacking IRF-3 (39). Given that TBK is critical for
activation of IRF-3, we would have expected significantly in-
creased virulence in these mice if the BBD-deleted virus was com-
pletely incapable of modulating TBK-1. This is an aspect of 34.5
function that clearly warrants closer scrutiny.
In conclusion, we have shown in this study that 34.5 is suffi-
cient for control of autophagy in DCs and that the BBD of 34.5 is
necessary for this control. In contrast to its activities in other cells,
34.5 allows autophagosomes to accumulate but interrupts au-
tophagic degradation of long-lived proteins in DCs, significantly
affecting presentation of intracellular antigens. This finding is im-
portant for enhancing our understanding of how adaptive immu-
nity develops to HSV and how 34.5 can facilitate evasion of both
innate and adaptive immunity. Currently, we are addressing the
role of autophagy control in APCs during HSV-1 infection in vivo
and investigating the DC-specific mechanisms that result in this
atypical mode of manipulation of autophagy by 34.5. This work
will serve to further elucidate the immune-modulatory activities
of HSV-1 with impact on vaccine development and antitumor
therapies using HSV as an oncolytic vector.
MATERIALS AND METHODS
Cells, viruses, and mice. BMDCs were generated and infected as previ-
ously described (70). DC2.4 cells are BMDC-derived immortalized cell
lines made available by Kenneth Rock (University of Massachusetts,
Worcester, MA) and kindly provided by Ed Usherwood (Dartmouth)
(50). All infection protocols for DC2.4 cells were as previously described
for BMDCs (71). The DC2.4-derived stably transduced cells were made
using the Clontech Lenti-X system. Briefly, 34.5 or 34.5BBD gene
sequences were cloned into pLVX-IRES-Hyg vectors by digestion of
pc34.5 and pc34.5BBD expression vectors (72) with Sau3AI and XbaI
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(New England Biolabs) and of the lentiviral vector with BamHI and XbaI,
thus placing the chicken beta-actin promoter upstream of 34.5 in the
vector. New pLVX-34.5 and pLVX-34.5dBBD or control pLVX-IRES-
Hyg vectors were then transfected into 293 Lenti-X cells along with helper
plasmid according to the manufacturer’s protocol. The lentiviruses pro-
duced were then used to transduce DC2.4 cells. Stable clones were isolated
using 250 g/ml hygromycin. Expressing clones were identified by West-
ern blotting and routinely propagated in hygromycin at a concentration
of 100 to 300 g/ml to ensure stability. HSV-1 strain 17 (WT) was the
background for all viruses in this study. The 34.5-null mutant, 34.5,
and the Beclin-binding domain mutant, BBD, were made as previously
described (40, 72). HSV-1 strain 17 34.5 tOVA was made using a trun-
cated cytoplasmic-retained chicken ovalbumin (OVA)-encoding plasmid
generously supplied by Charles Sentman (Dartmouth) (73). The sequence
was cloned into pCI using EcoRI and XhoI/SalI digests. The promoter and
gene sequences from the resulting plasmid, pCI-tOVA, were transferred
into the pUIC17 vector using BamHI/BglII cutting. This vector possesses
a sequence from the UL49 and UL50 genes of strain 17 separated by a BglII
restriction site (74). The pUIC17-tOVA vector was cotransfected into
Vero cells with 34.5 infectious DNA to make strain 17 34.5 tOVA by
homologous recombination as previously described (75). Viruses were
screened by PCR and Western blotting for expression of truncated OVA
(data not shown). OT-II mice, originally developed by Francis Carbone
(57), were generously provided by Ed Usherwood (Dartmouth).
Fluorescence microscopy. Cells were plated on glass coverslips and
infected at the indicated multiplicities of infection (MOIs) for 8 or 16 h.
Where applied, 100 M bafilomycin A1 was added for 6 h. All samples
were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS)
for 20 min at room temperature, blocked, and permeabilized in 2% goat
serum (Vector Laboratories), 1% bovine serum albumen (BSA) (Sigma),
0.1% cold fish gelatin (Sigma), 0.1% Triton X-100 (Sigma) in PBS, pH 7.2,
for 20 min. Primary and secondary antibodies were sequentially added,
diluted in 5% goat serum in PBS. Coverslips were mounted using
Vectashield mounting medium (Vector Laboratories). Antibodies used
were specific to LC3 (1:400) (MBL PD014), p62 (1:1,000) (Novus NBP1-
48320), ICP0 (1:1,500) (Virusys, HA027), or ICP8 (1:700) (kindly pro-
vided by David Knipe, Harvard Medical School). Microscopy was per-
formed on a Zeiss AX10 microscope fitted with a QImaging cooled mono
14-bit camera. Images were captured at either 66 magnification for
puncta quantification or 100 magnification for the images shown in this
study. Equivalent contrast enhancement was applied to all images using
Q-Capture Pro software.
When quantifying populations accumulating p62 or LC3 puncta,
antibody-positive puncta were counted, and those with a minimum of 4
(LC3) or 5 (p62) puncta per cell were scored positive (76). Total cell
population, for determining ratios, were derived by counting DAPI (4=,6-
diamidino-2-phenylindole)-positive nuclei, and infected cell populations
were determined by counting nuclei costaining for ICP8 or ICP0. All
fluorescence ratios were determined by imaging four or more fields and
counting a minimum of 60 cells.
Western blotting. LC3 conversion and p62 accumulation assays were
performed on DCs and BMDCs at an MOI of 8. Cells were infected for 8 or
16 h and treated with bafilomycin as described for fluorescence micros-
copy. Stable cells were induced to phosphorylate eIF2 using poly(I:C) at
a concentration of 20 g/ml or infected with the 34.5 strain, at an MOI
of 8 for 12 h. Cell lysate was prepared by rinsing cells in PBS and resus-
pending them in sample buffer (62.5 mM Tris [lsqb]pH 6.8[rsqb], 4.65%
SDS, 20% glycerol, 10% -mercaptoethanol, 0.025% bromophenol blue)
(Sigma). Membranes were probed with rabbit polyclonal anti LC3 (MBL
PD014) or p62 (Novus NBP1-48320) using antibody concentrations of
1:1,000 and anti--tubulin antibody (Novus NB100-690) as a loading
control at 1:2,000. Anti-phospho-eIF2 (BioSource, AH01182) antibod-
ies were used at 1:800, and anti-34.5 antibodies (a generous gift from Ian
Mohr, New York University) were used at 1:1,000. Secondary goat-anti-
rabbit or mouse horseradish peroxidase antibodies (Bio-Rad) were used
in conjunction with ECL Western blotting substrate (Thermo) and de-
tected on an Alpha Innotech Fluor Chem Q multi-imager. The molecular
weights (MW) of bands of interest were determined by interpolation from
MW 15.3 to 101.4 (Bio-Rad). Images were captured, molecular weights
were determined, contrast was optimized, and band density was quanti-
fied using AlphaImager software. All blots are representative of a mini-
mum of two experiments.
Starvation/survival assay. Cells were starved by replacing media with
Earl’s balanced salt solution for 2 h. Cells were then analyzed for cell
viability by propidium iodide and Alexa Fluor 647-annexin V (BioLeg-
end) staining according to the manufacturer’s protocol. Flow cytometry
and data analysis were performed on an Accuri flow cytometer (BD Bio-
sciences).
T cell response assay and flow cytometry. Stably transduced DC2.4
cells were mock infected or infected with the 17 34.5 or 17 34.5 tOva
strains at an MOI of 8.0, incubated for 1 h, and rinsed three times in
Hank’s balanced salt solution (HBSS). Whole OT-II splenocytes were
then added at a ratio of 4 splenocytes to 1 DC. For positive controls, PMA
and ionomycin were added at concentrations of 10 ng/ml and 1 g/ml,
respectively. The coculture was incubated for 44 h, and cells were har-
vested for analysis by flow cytometry using anti-CD4-PercP and anti-
CD44-FITC antibodies (Biolegends). Cells were gated based on the high
surface expression of CD4, and gated cells were analyzed for high surface
expression of CD44. All flow cytometry and analysis were performed on a
BD Accuri C6 using CFlow software. Relative high-CD44 staining was
expressed as a ratio relative to mock-infected cells.
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